Ratings by William Blair (Raju Prasad)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/2/2021 Assembly Biosciences ASMB Downgrade Market Perform
(Outperform)
3.80
(3.23)
-15% Details
8/10/2021 bluebird bio BLUE New Coverage Market Perform
(N/A)
25.03
(18.32)
-26.81% Details
7/12/2021 Verve Therapeutics VERV New Coverage Outperform
(N/A)
46.00
(59.88)
30.17% Details
6/8/2021 bluebird bio BLUE Maintain Market Perform
(N/A)
 
 
  Details
3/12/2021 Selecta Biosciences SELB Upgrade Outperform
(Market Perform)
3.90
(4.45)
14.1% Details
2/25/2021 Global Blood Therapeutics GBT Downgrade Market Perform
(Outperform)
49.19
(28.03)
-43.02% Details
2/24/2021 Generation Bio GBIO New Coverage Outperform
(N/A)
37.18
(25.13)
-32.41% Details
2/24/2021 Taysha Gene Therapies TSHA New Coverage Outperform
(N/A)
29.10
(19.90)
-31.62% Details
2/16/2021 bluebird bio BLUE Downgrade Market Perform
(Outperform)
45.76
(18.32)
-59.97% Details
11/2/2020 bluebird bio BLUE Upgrade Outperform
(Market Perform)
51.71
(45.76)
-11.51% Details
8/5/2020 Beam Inc BEAM New Coverage Outperform
(N/A)
19.41
(102.91)
430.19% Details
7/31/2020 Alexion Pharmaceuticals ALXN Downgrade Market Perform
(Outperform)
104.60
(182.01)
74.01% Details
2/25/2020 Precision BioSciences Inc. DTIL New Coverage Outperform
(N/A)
8.24
(12.86)
56.07% Details
12/9/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
11/19/2019 CRISPR Therapeutics CRSP Upgrade Outperform
(Market Perform)
58.53
(124.52)
112.75% Details
9/26/2019 Alexion Pharmaceuticals ALXN New Coverage Outperform
(N/A)
100.40
(182.01)
81.28% Details
9/19/2019 bluebird bio BLUE Maintain Market Perform
(N/A)
 
 
  Details
8/12/2019 bluebird bio BLUE Downgrade Market Perform
(Outperform)
125.23
(18.32)
-85.37% Details
3/14/2019 Cellectis CLLS New Coverage Outperform
(N/A)
18.71
(14.43)
-22.88% Details
3/14/2019 CRISPR Therapeutics CRSP New Coverage Market Perform
(N/A)
39.41
(58.53)
48.52% Details
3/14/2019 Allogene ALLO New Coverage Outperform
(N/A)
26.72
(25.38)
-5.01% Details
3/7/2019 Spark Therapeutics ONCE Downgrade Market Perform
(Outperform)
113.70
(110.05)
-3.21% Details
1/17/2019 Loxo Oncology LOXO Downgrade Market Perform
(Outperform)
233.26
(234.80)
0.66% Details
11/13/2018 LogicBio Therapeutics LOGC New Coverage Outperform
(N/A)
15.11
(4.65)
-69.23% Details
11/7/2018 Audentes Therapeutics BOLD Downgrade Market Perform
(Outperform)
29.13
(59.97)
105.87% Details
10/30/2018 Celyad SA CYAD New Coverage Outperform
(N/A)
23.58
(4.40)
-81.34% Details
9/26/2018 Krystal Biotech KRYS Maintain Outperform
(N/A)
 
 
  Details